JP2018115201A5 - - Google Patents

Download PDF

Info

Publication number
JP2018115201A5
JP2018115201A5 JP2018061990A JP2018061990A JP2018115201A5 JP 2018115201 A5 JP2018115201 A5 JP 2018115201A5 JP 2018061990 A JP2018061990 A JP 2018061990A JP 2018061990 A JP2018061990 A JP 2018061990A JP 2018115201 A5 JP2018115201 A5 JP 2018115201A5
Authority
JP
Japan
Prior art keywords
atoms
substituted
unsubstituted
unbranched
branched alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018061990A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018115201A (ja
JP6763904B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018115201A publication Critical patent/JP2018115201A/ja
Publication of JP2018115201A5 publication Critical patent/JP2018115201A5/ja
Application granted granted Critical
Publication of JP6763904B2 publication Critical patent/JP6763904B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018061990A 2011-05-23 2018-03-28 ピリジン−及びピラジン誘導体 Expired - Fee Related JP6763904B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161488997P 2011-05-23 2011-05-23
US61/488,997 2011-05-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016124235A Division JP2016196492A (ja) 2011-05-23 2016-06-23 ピリジン−及びピラジン誘導体

Publications (3)

Publication Number Publication Date
JP2018115201A JP2018115201A (ja) 2018-07-26
JP2018115201A5 true JP2018115201A5 (esLanguage) 2020-08-13
JP6763904B2 JP6763904B2 (ja) 2020-09-30

Family

ID=45976540

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014512837A Expired - Fee Related JP6054954B2 (ja) 2011-05-23 2012-04-11 ピリジン−及びピラジン誘導体
JP2016124235A Pending JP2016196492A (ja) 2011-05-23 2016-06-23 ピリジン−及びピラジン誘導体
JP2018061990A Expired - Fee Related JP6763904B2 (ja) 2011-05-23 2018-03-28 ピリジン−及びピラジン誘導体

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2014512837A Expired - Fee Related JP6054954B2 (ja) 2011-05-23 2012-04-11 ピリジン−及びピラジン誘導体
JP2016124235A Pending JP2016196492A (ja) 2011-05-23 2016-06-23 ピリジン−及びピラジン誘導体

Country Status (22)

Country Link
US (1) US9273029B2 (esLanguage)
EP (1) EP2714677B1 (esLanguage)
JP (3) JP6054954B2 (esLanguage)
KR (1) KR101581522B1 (esLanguage)
CN (1) CN103748086B (esLanguage)
AU (1) AU2012259333B2 (esLanguage)
BR (1) BR112013029640A2 (esLanguage)
CA (1) CA2832605C (esLanguage)
DK (1) DK2714677T3 (esLanguage)
EA (1) EA023364B1 (esLanguage)
ES (1) ES2699256T3 (esLanguage)
HR (1) HRP20181884T1 (esLanguage)
IL (1) IL229528A (esLanguage)
LT (1) LT2714677T (esLanguage)
MX (1) MX352975B (esLanguage)
PL (1) PL2714677T3 (esLanguage)
PT (1) PT2714677T (esLanguage)
RS (1) RS58015B1 (esLanguage)
SG (1) SG194105A1 (esLanguage)
SI (1) SI2714677T1 (esLanguage)
WO (1) WO2012161877A1 (esLanguage)
ZA (1) ZA201307429B (esLanguage)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20181884T1 (hr) * 2011-05-23 2019-01-11 Merck Patent Gmbh Derivati piridina i pirazina
GB201303109D0 (en) 2013-02-21 2013-04-10 Domainex Ltd Novel pyrimidine compounds
AU2014304953B2 (en) * 2013-08-07 2018-02-22 Merck Patent Gmbh Piperidine urea derivatives
WO2015089481A2 (en) 2013-12-13 2015-06-18 Dana-Farber Cancer Institute, Inc. Methods to treat lymphoplasmacytic lymphoma
JP6879740B2 (ja) 2013-12-13 2021-06-02 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド リンパ形質細胞性リンパ腫を処置する方法
WO2015121812A1 (en) * 2014-02-12 2015-08-20 Iteos Therapeutics Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
MD20160118A2 (ro) 2014-05-15 2017-04-30 Iteos Therapeutics Derivaţi ai pirolidin-2,5-dionei, compoziţii farmaceutice şi metode de utilizare ca inhibitori ai IDO1
TW201613916A (en) 2014-06-03 2016-04-16 Gilead Sciences Inc TANK-binding kinase inhibitor compounds
ES2881195T3 (es) 2014-09-26 2021-11-29 Gilead Sciences Inc Derivados de aminotriazina útiles como compuestos inhibidores de quinasas que se unen a TANK
US9994547B2 (en) 2014-10-06 2018-06-12 Takeda Pharmaceutical Company Limited Heteroarylamide inhibitors of TBK1
EP3715346B1 (en) 2014-10-22 2024-01-03 Dana-Farber Cancer Institute, Inc. Thiazolyl-containing compounds for treating proliferative diseases
MA41598A (fr) * 2015-02-25 2018-01-02 Constellation Pharmaceuticals Inc Composés thérapeutiques de pyridazine et leurs utilisations
BR112017019699A2 (pt) 2015-03-17 2018-09-04 Pfizer Inc. derivados substituídos por 3-indol, composições farmacêuticas e métodos para uso
US10544095B2 (en) 2015-08-10 2020-01-28 Pfizer Inc. 3-indol substituted derivatives, pharmaceutical compositions and methods for use
JP2019500368A (ja) 2015-12-17 2019-01-10 ギリアード サイエンシーズ, インコーポレイテッド Tank結合キナーゼ阻害剤化合物
EP3390387B1 (en) 2015-12-18 2021-11-17 Bayer Pharma Aktiengesellschaft Heteroarylbenzimidazole compounds
WO2017207534A1 (en) 2016-06-03 2017-12-07 Bayer Pharma Aktiengesellschaft Substituted heteroarylbenzimidazole compounds
EP3487851B1 (en) 2016-07-20 2021-10-20 Novartis AG Aminopyridine derivatives and their use as selective alk-2 inhibitors
DE102016113714A1 (de) 2016-07-26 2018-02-01 Rosa Karl Transfektionsverfahren mit nicht-viralen Genliefersystemen
GB201702947D0 (en) 2017-02-23 2017-04-12 Domainex Ltd Novel compounds
TWI771410B (zh) 2017-04-27 2022-07-21 日商石原產業股份有限公司 N-(4-吡啶基)菸鹼醯胺化合物或其鹽
AU2020388638A1 (en) 2019-11-22 2022-06-30 Incyte Corporation Combination therapy comprising an ALK2 inhibitor and a JAK2 inhibitor
US11723899B2 (en) 2020-06-16 2023-08-15 Incyte Corporation ALK2 inhibitors for the treatment of anemia
CN116710090A (zh) * 2020-10-09 2023-09-05 Napa医疗有限公司 Cd38的杂芳基酰胺抑制剂
CN116099004B (zh) * 2022-12-30 2024-01-30 深圳开悦生命科技有限公司 Rna解旋酶dhx33抑制剂在制备用于治疗膀胱癌的药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
SE0102438D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
SE0102439D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
SE0203754D0 (sv) 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
SE0203752D0 (sv) 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
EP1715867A4 (en) * 2004-02-12 2009-04-15 Merck & Co Inc BIPYRIDYLAMIDE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5
TW200800203A (en) * 2006-03-08 2008-01-01 Astrazeneca Ab New use
WO2007129044A1 (en) 2006-05-03 2007-11-15 Astrazeneca Ab Thiazole derivatives and their use as anti-tumour agents
WO2009030890A1 (en) 2007-09-03 2009-03-12 University Court Of The University Of Dundee Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma
WO2009053737A2 (en) 2007-10-25 2009-04-30 Astrazeneca Ab Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
US20100056524A1 (en) * 2008-04-02 2010-03-04 Mciver Edward Giles Compound
SI3354650T1 (sl) * 2008-12-19 2022-06-30 Vertex Pharmaceuticals Incorporated Spojine, uporabne kot zaviralci ATR kinaze
GB0903759D0 (en) * 2009-03-04 2009-04-15 Medical Res Council Compound
US8198285B2 (en) * 2010-01-19 2012-06-12 Astrazeneca Ab Pyrazine derivatives
HRP20181884T1 (hr) * 2011-05-23 2019-01-11 Merck Patent Gmbh Derivati piridina i pirazina

Similar Documents

Publication Publication Date Title
JP2018115201A5 (esLanguage)
JP2016196492A5 (esLanguage)
JP2019031560A5 (esLanguage)
JP2010532768A5 (esLanguage)
JP2018127459A5 (esLanguage)
JP2016506369A5 (esLanguage)
JP2016526558A5 (esLanguage)
JP2016006118A5 (esLanguage)
JP2016530259A5 (esLanguage)
JP2016515560A5 (esLanguage)
JP2016056183A5 (esLanguage)
JP2016503797A5 (esLanguage)
JP2014518884A5 (esLanguage)
JP2015515961A5 (esLanguage)
JP2012092103A5 (esLanguage)
JP2011530545A5 (esLanguage)
JP2015508103A5 (esLanguage)
JP2015517574A5 (esLanguage)
JP2007514773A5 (esLanguage)
JP2012530758A5 (esLanguage)
JP2017501237A5 (esLanguage)
JP2020097596A5 (esLanguage)
JP2009501198A5 (esLanguage)
JP2016531126A5 (esLanguage)
JP2016501185A5 (esLanguage)